Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

NewAmsterdam Pharma Company N.V. (NAMS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

20.20

+0.08

(+0.40%)

At close: 04:00PM EST

21.21

+1.01

(+5.00%)

After hours:

07:56PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.87B
Enterprise Value	1.44B
Trailing P/E	29.99
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	54.19
Price/Book (mrq)	4.93
Enterprise Value/Revenue	42.98
Enterprise Value/EBITDA	27.63

Trading Information

Stock Price History

Beta (5Y Monthly)	-0.00
52-Week Change ³	104.87%
S&P500 52-Week Change ³	31.18%
52 Week High ³	26.35
52 Week Low ³	8.90
50-Day Moving Average ³	19.07
200-Day Moving Average ³	19.49

Share Statistics

Avg Vol (3 month) ³	398.89k
Avg Vol (10 day) ³	1.03M
Shares Outstanding ⁵	92.39M
Implied Shares Outstanding ⁶	92.39M
Float ⁸	36.26M
% Held by Insiders ¹	0.25%
% Held by Institutions ¹	89.54%
Shares Short (Oct 31, 2024) ⁴	718.04k
Short Ratio (Oct 31, 2024) ⁴	2.92
Short % of Float (Oct 31, 2024) ⁴	1.29%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	0.78%
Shares Short (prior month Sep 30, 2024) ⁴	442.96k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-85.89%

Management Effectiveness

Return on Assets (ttm)	-29.27%
Return on Equity (ttm)	-47.37%

Income Statement

Revenue (ttm)	33.59M
Revenue Per Share (ttm)	0.37
Quarterly Revenue Growth (yoy)	889.80%
Gross Profit (ttm)	N/A
EBITDA	-184.06M
Net Income Avi to Common (ttm)	-198.92M
Diluted EPS (ttm)	-2.21
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	422.73M
Total Cash Per Share (mrq)	4.58
Total Debt (mrq)	506k
Total Debt/Equity (mrq)	0.13%
Current Ratio (mrq)	10.61
Book Value Per Share (mrq)	4.11

Cash Flow Statement

Operating Cash Flow (ttm)	-154.16M
Levered Free Cash Flow (ttm)	-108.73M